Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION USP

Last updated on 2019-05-22 History
Report ID 60109
Drug Identification Number 02391090
Brand name LABETALOL HYDROCHLORIDE INJECTION USP
Common or Proper name LABETALOL
Company Name PFIZER CANADA ULC
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 20ML
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-15
Estimated end date
Actual end date 2019-05-21
Shortage status Resolved
Updated date 2019-05-22
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-05-22 English Compare
v18 2019-05-21 French Compare
v17 2019-05-21 English Compare
v16 2019-04-23 French Compare
v15 2019-04-23 English Compare
v14 2019-04-23 English Compare
v13 2019-02-27 French Compare
v12 2019-02-27 English Compare
v11 2019-01-18 French Compare
v10 2019-01-18 English Compare
v9 2018-12-12 French Compare
v8 2018-12-12 English Compare
v7 2018-11-28 French Compare
v6 2018-11-28 English Compare
v5 2018-11-07 English Compare
v4 2018-11-01 French Compare
v3 2018-11-01 English Compare
v2 2018-09-06 French Compare
v1 2018-09-06 English Compare